Tirbanibulin
Tirbanibulin
Tirbanibulin (pronounced as tee-r-ba-ni-byoo-lin) is a small molecule inhibitor that is used in the treatment of various types of cancer. It is also known by its trade name, Klisyri.
Etymology
The name "Tirbanibulin" is derived from the chemical structure of the drug. The prefix "Tir-" is derived from the chemical name "tubulin inhibitor", which describes the drug's mechanism of action. The suffix "-bulin" is a common suffix used in the names of drugs that inhibit tubulin, a protein involved in cell division.
Mechanism of Action
Tirbanibulin works by inhibiting the polymerization of tubulin, a protein that forms the microtubules necessary for cell division. By preventing the formation of these microtubules, tirbanibulin stops cancer cells from dividing and growing.
Uses
Tirbanibulin is used in the treatment of actinic keratosis, a skin condition that can lead to skin cancer. It is also being studied for use in the treatment of other types of cancer, including non-small cell lung cancer and bladder cancer.
Side Effects
Common side effects of tirbanibulin include skin irritation, redness, and swelling at the application site. More serious side effects can include allergic reactions and changes in skin color.
Related Terms
External links
- Medical encyclopedia article on Tirbanibulin
- Wikipedia's article - Tirbanibulin
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski